Atlas Trials

Phase 2 Study of VX-950, Pegasys and Copegus in Hepatitis C

Clinical trial NCT00262483 · COMPLETED

Trial details

NCT number
NCT00262483
Sponsor
Vertex Pharmaceuticals Incorporated
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Hepatitis C
Start date
2005-12-01
Enrollment
12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.